PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS
The present invention relates to compounds of formula (I) or (II)pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 12. Juli Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
MÁLNÁSI-CSIZMADIA ANDRÁS [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-07-12, Last update posted on www.tib.eu: 2024-04-23, Last updated: 2024-04-26 |
|---|
| Patentnummer: |
EP3781263 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA000505609 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA000505609 | ||
| 003 | DE-627 | ||
| 005 | 20240426160242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA000505609 | ||
| 035 | |a (EPA)EP3781263 | ||
| 035 | |a (EPA)89992670 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a MÁLNÁSI-CSIZMADIA ANDRÁS |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-07-12, Last update posted on www.tib.eu: 2024-04-23, Last updated: 2024-04-26 | ||
| 520 | |a The present invention relates to compounds of formula (I) or (II)pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a GYIMESI MÁTÉ |e verfasserin |4 aut | |
| 700 | 0 | |a SZABÓ ANDRÁS |e verfasserin |4 aut | |
| 700 | 0 | |a HÁRI PÉTER |e verfasserin |4 aut | |
| 700 | 0 | |a KUMAR SUTHAR SHARAD |e verfasserin |4 aut | |
| 700 | 0 | |a KOVÁCS MIHÁLY |e verfasserin |4 aut | |
| 700 | 0 | |a HORVÁTH ÁDÁM ISTVÁN |e verfasserin |4 aut | |
| 700 | 0 | |a PÉNZES MÁTÉ |e verfasserin |4 aut | |
| 700 | 0 | |a LÖRINCZ ISTVÁN |e verfasserin |4 aut | |
| 700 | 0 | |a RÉPÁSI JÓZSEF |e verfasserin |4 aut | |
| 700 | 0 | |a SZÖNYEGI ZOLTÁN |e verfasserin |4 aut | |
| 700 | 0 | |a SIMON ZOLTÁN |e verfasserin |4 aut | |
| 700 | 0 | |a VÉGNER LÁSZLÓ |e verfasserin |4 aut | |
| 700 | 0 | |a BÁTORI SÁNDOR |e verfasserin |4 aut | |
| 700 | 0 | |a HORVÁTH VAJK |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 12. Juli |
| 773 | 1 | 8 | |g year:2023 |g day:12 |g month:07 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89992670/publication/EP3781263A1?q=EP3781263 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 12 |c 07 | ||